| 产品名称： | Empedobacter brevis (Holmes and Owen) Vandamme et al. |
|---|---|
| 商品货号： | TS209736 |
| Deposited As： | Flavobacterium breve (Lustig) Bergey et al. |
| Strain Designations： | S-15 |
| Application： | Produces inosinic acid 5-inosinic acid, IMP, inosine monophosphate |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | yes |
| Comments： | Taxonomy |
| Medium： | ATCC® Medium 44: Brain Heart Infusion Agar/Broth |
| Growth Conditions： | Temperature: 30.0°C |
| Name of Depositor： | Ajinomoto Co., Inc. |
| U.S. Patent Number： | |
| References： | Katagiri H, et al. Process for preparing inosinic acid. US Patent 3,150,058 dated Sep 22 1964 Holmes B, et al. Revised description, from clinical strains, of Flavobacterium breve (Lustig) Bergey et al. 1923 and proposal of the neotype strain. Int. J. Syst. Bacteriol. 28: 201-208, 1978. |
| Cross References： | Nucleotide (GenBank) : M33888 F.breve 5S ribosomal RNA. Nucleotide (GenBank) : M59052 Flavobacterium breve 16S ribosomal RNA. |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Empedobacter brevis (Holmes and Owen) Vandamme et al. |
|---|---|
| 商品货号： | TS209736 |
| Deposited As： | Flavobacterium breve (Lustig) Bergey et al. |
| Strain Designations： | S-15 |
| Application： | Produces inosinic acid 5-inosinic acid, IMP, inosine monophosphate |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | yes |
| Comments： | Taxonomy |
| Medium： | ATCC® Medium 44: Brain Heart Infusion Agar/Broth |
| Growth Conditions： | Temperature: 30.0°C |
| Name of Depositor： | Ajinomoto Co., Inc. |
| U.S. Patent Number： | |
| References： | Katagiri H, et al. Process for preparing inosinic acid. US Patent 3,150,058 dated Sep 22 1964 Holmes B, et al. Revised description, from clinical strains, of Flavobacterium breve (Lustig) Bergey et al. 1923 and proposal of the neotype strain. Int. J. Syst. Bacteriol. 28: 201-208, 1978. |
| Cross References： | Nucleotide (GenBank) : M33888 F.breve 5S ribosomal RNA. Nucleotide (GenBank) : M59052 Flavobacterium breve 16S ribosomal RNA. |
